PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes

Zaidman, Daniel, Prilusky, Jaime, London, Nir·2020·Journal of Chemical Information and Modeling

DOI 10.1021/acs.jcim.0c00589

Cited by (227)

Items 101–200 of 227

Machine learning in targeted protein degradation drug design: a technical review of PROTACs and molecular glues
Chieh‐Te Lin, Ya‐Ping Shiau, Chu‐Chung Lin · 2025 · Drug Discovery Today
Protein–Protein Interaction Prediction for Targeted Protein Degradation
Orasch, Oliver, Weber, Noah, Müller, Michael, Amanzadi, Amir, Gasbarri, Chiara, Trummer, Christopher · 2022 · International Journal of Molecular Sciences
Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications
Qiong Li, Li Zhou, Siyuan Qin, Zhao Huang, Bowen Li, Bowen Li, Mei Yang, Edouard Collins Nice, Huili Zhu, Canhua Huang · 2023 · European Journal of Medicinal Chemistry
Methods for computer-assisted PROTAC design
Evianne Rovers, Matthieu Schapira · 2023 · Methods in enzymology on CD-ROM/Methods in enzymology
An outlook on structural biology after A lpha F old: tools, limits and perspectives
Serena Rosignoli, Maddalena Pacelli, Francesca Manganiello, Alessandro Paiardini · 2024 · FEBS Open Bio
PRosettaC outperforms AlphaFold3 for modeling PROTAC ternary complexes
Schulz, Joseph M., Schürer, Sarah I., Reynolds, Robert C., Schürer, Stephan C. · 2025 · Scientific Reports
Proteolysis Targeting Chimeric Molecules: Tuning Molecular Strategies for a Clinically Sound Listening
Federica Pedrucci, Claudia Pappalardo, Giovanni Marzaro, Nicola Ferri, Alberto Ferlin, Luca De Toni · 2022 · International Journal of Molecular Sciences
From classic medicinal chemistry to state‐of‐the‐art interdisciplinary medicine: Recent advances in proteolysis‐targeting chimeras technology
Xuyang Zhao, Yifan Chen, Huang Su, Liqin Zhang · 2023 · Interdisciplinary medicine
Targeted degrader technologies as prospective SARS-CoV-2 therapies
Rabia Khurshid, Joseph M. Schulz, Jiaming Hu, Timothy S. Snowden, Robert C. Reynolds, Stephan C. Schürer · 2023 · Drug Discovery Today
MEGA PROTAC, MEGA DOCK-based PROTAC mediated ternary complex formation pipeline with sequential filtering and rank aggregation
Sadettin Y. Ugurlu, David McDonald, Ramazan Enisoglu, Zexuan Zhu, Shan He · 2025 · Scientific Reports
Advancing target validation with PROTAC technology
M. Leora Spitz, Aseel Kashkush, Raphael I. Benhamou · 2025 · Expert Opinion on Drug Discovery
PROTACting the kinome with covalent warheads
Deep Rohan Chatterjee, Saumya Kapoor, Meenakshi Jain, Rudradip Das, Moumita Ghosh Chowdhury, Amit Shard · 2022 · Drug Discovery Today
A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology
Qi Huang, Linghao Hu, Haowen Chen, Bingjie Yang, Xun Sun, Mingliang Wang · 2025 · Journal of Medicinal Chemistry
A comprehensive primer and review of PROTACs and their In Silico design
Jacopo Zattoni, Paola Vottero, Gea Carena, Chiara Uliveto, Giulia Pozzati, Benedetta Morabito, Ebenezea Gitari, Jack A. Tuszyński, Maral Aminpour · 2025 · Computer Methods and Programs in Biomedicine
Mapping the energy landscape of PROTAC-mediated protein-protein interactions
José A. Villegas, Tasneem M. Vaid, Michael E. Johnson, Terry W. Moore · 2023 · Computational and Structural Biotechnology Journal
Bifunctional robots inducing targeted protein degradation
Masilamani Elizabeth Sobhia, Harish Kumar, Sonia Kumari · 2023 · European Journal of Medicinal Chemistry
From serendipity to strategy: molecular glue degraders in cancer therapeutics
Darling, Sarah, Bajrami, Ilirjana, West, Stephen C. · 2025 · Critical Reviews in Biochemistry and Molecular Biology
How to target membrane proteins for degradation: Bringing GPCRs into the TPD fold
Bogusława Korona, Laura S. Itzhaki · 2024 · Journal of Biological Chemistry
Optimization of the PROTAC linker region of the proteasome substrate receptor hRpn13 rationalized by structural modeling with molecular dynamics
Xiuxiu Lu, Venkata R. Sabbasani, Bakar A. Hassan, Rolf E. Swenson, Kylie J. Walters · 2025 · Journal of Biological Chemistry
Harnessing the Power of Natural Products for Targeted Protein Degradation
Bo Zhu, Zheng Wu, Yiwen Shou, Kaili Zhao, Qinpei Lu, Jiang‐Jiang Qin, Hongwei Guo · 2025 · Medicinal Research Reviews
Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation
Rajamanikkam Kamaraj, Ivana Mejdrová, Mária Krutáková, Tomáš Smutný, Kryštof Škach, Klára Dohnalová, Lucie Smutná, Dharani Sai Sreekanth Nellore, Jan Dusek, Karel Chalupský et al. · 2025 · Journal of Medicinal Chemistry
Dégradation induite des protéines par des molécules PROTAC et stratégies apparentées : développements à visée thérapeutique
Michèle Reboud‐Ravaux · 2021 · Biologie Aujourd hui
PROTAC-induced protein structural dynamics in targeted protein degradation
Kingsley Y Wu, Ta I Hung, Chia‐en A. Chang · 2024 · eLife
Development of PROTACs targeting estrogen receptor: an emerging technique for combating endocrine resistance
Rouming Peng, Xin Liu, Chun‐Chi Chen, Rey‐Ting Guo, Jian Min · 2024 · RSC Medicinal Chemistry
DNA-Templated Spatially Controlled Proteolysis Targeting Chimera for Cyclin D1–CDK4/6 Complex Protein Degradation
Rong Zheng, Abhay Prasad, Deeksha Satyabola, Yang Xu, Subhajit Roy, Yichen Yan, Petr Šulc, Hao Yan · 2025 · Journal of the American Chemical Society
Reviewing the toolbox for degrader development in oncology
Joel O. Cresser-Brown, Graham P. Marsh, Hannah J. Maple · 2021 · Current Opinion in Pharmacology
The rise of targeting chimeras (TACs): next-generation medicines that preempt cellular events
Scott A. Hollingsworth, Scott Arne Johnson, Pouyan Khakbaz, Yilin Meng, Varnavas D. Mouchlis, Olivia Pierce, Vera D. Prytkova, Erik Sebastian Vik, Dahlia R. Weiss, Veerabahu Shanmugasundaram · 2023 · Medicinal Chemistry Research
Atomic-Resolution Prediction of Degrader-mediated Ternary Complex Structures by Combining Molecular Simulations with Hydrogen Deuterium Exchange
Dixon, Tom, MacPherson, Derek, Mostofian, Barmak, Dauzhenka, Taras, Lotz, Samuel, McGee, Dwight, Shechter, Sharon, Shrestha, Utsab R., Wiewiora, Rafal, McDargh, Zachary A. et al. · 2021
Accommodating Statistical and Physics-Based Computational Protocols for Molecular Glue Model and Evaluation
Qixuan Xu, Wenlang Liu, Hao Liu, Zheng Zheng · 2025 · Journal of Chemical Information and Modeling
Development of potent JAK1/2 PROTAC degraders for the treatment of inflammatory bowel diseases
Gang Li, Yanghui Ou, Yuanhui Liu, Jun Wang, Zhuoran He, Xinshan Deng, Wei Pan, Mian Peng, Chuxun Zhou, Jiayu Li et al. · 2025 · European Journal of Medicinal Chemistry
Machine learning, docking, or physics for structure prediction of ligand-induced ternary complexes
Riccardo Solazzo, Shuyu Chen, Sereina Riniker · 2026 · Current Opinion in Structural Biology
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design
Tommaso Palomba, Giusy Tassone, Carmine Vacca, Matteo Bartalucci, Aurora Valeri, Cecilia Pozzi, Simon Cross, Lydia Siragusa, Jenny Desantis · 2022 · International Journal of Molecular Sciences
N-Heterocycle based Degraders (PROTACs) Manifesting Anticancer Efficacy: Recent Advances
Suddhasatwa Banerjee, Sachin Sharma, Amandeep Thakur, Ritika Sachdeva, Ram Sharma, Kunal Nepali, Jing‐Ping Liou · 2023 · Current Drug Targets
Selection of DNA-encoded Chemical Libraries for Compounds that can Induce Protein Ubiquitination
Cen Huang, Xing‐Yuan Liu, Xinyuan Wu, Ling Hua Meng, Xiaojie Lu, Xiaoyu Li · 2024 · ChemRxiv
Targeted Protein Degradation of NUDT5 Reveals an Unexpected Non-Enzymatic Role in 6-Thioguanine-Mediated Toxicity
Anne-Sophie M. C. Marques, Ludwig G. Bauer, Tuan Anh Nguyen, Alejandro Gonzalez Orta, Jan L. Venne, Lai Cheng, Esra Balıkçı, Barr Tivon, Nir London, Stefan Kubicek et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
TRIM21-Driven Degradation of BRD4: Development of Heterobifunctional Degraders and Investigation of Recruitment and Selectivity Mechanisms
Liyun Zhang, Qingyang Wang, Xiaomei Li, Xuemin Cheng, Longying Cai, Anping Guo, Lanjun Zhang, Hong Hu, Mei Wu, Xianyang Li et al. · 2025 · Journal of Chemical Information and Modeling
Data-Driven Generation of Conformational Ensembles and Ternary Complexes for PROTAC and Other Chimera Systems
Fabio Montisci, Laura Friggeri, Kepa Koldo Burusco, Patrick McCabe, Bojana Popovic, Jason C. Cole · 2025 · Journal of Chemical Information and Modeling
Computational Modeling of PROTAC Ternary Complexes as Ensembles Using SILCS-xTAC
Erik B. Nordquist, Mingtian Zhao, Wenbo Yu, Alexander D. MacKerell · 2025 · Journal of Chemical Information and Modeling
Methods to Study the Molecular Mechanism and Drive the Design of Protein Degraders
Charlotte Crowe, Alessio Ciulli · 2026 · Chemical Reviews
Design and Evaluation of PROTACs Targeting Acyl Protein Thioesterase 1
Luís A. R. Carvalho, Bárbara B. Sousa, Daniel Zaidman, Hannah Kiely‐Collins, Gonçalo J. L. Bernardes · 2024 · ChemBioChem
Identification of ligand linkage vectors for the development of p300/CBP degraders
Duncan K. Brownsey, Ben C. Rowley, Evgueni Gorobets, Koichiro Mihara, Ranjan Maity, James W. Papatzimas, Benjamin S. Gelfand, Morley Donald Hollenberg, Nizar Jacques Bahlis, Darren J. Derksen · 2022 · RSC Medicinal Chemistry
Quantum Mechanics-Based Ranking of Predicted Proteolysis Targeting Chimeras-Mediated Ternary Complexes
Stefania Monteleone, Iñaki Morao, Dmitri G. Fedorov, Tahsin F. Kellici · 2025 · ACS Medicinal Chemistry Letters
AI‐Based Prediction of PROTAC‐ and Molecular Glue‐Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz‐2
Lino Riepenhausen, Anne‐Christin Sarnow, Dina Robaa, Wolfgang Sippl · 2026 · Archiv der Pharmazie
HADDOCK-Guided modeling and molecular simulations of cereblon-based ternary complexes: Development of novel PROTACs for Ataxia telangiectasia and RAD3-Related (ATR) kinase
Anne‐Christin Sarnow, Husam Nassar, Abdallah M. Alfayomy, Dina Robaa, Wolfgang Sippl · 2025 · Computers in Biology and Medicine
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders
Ashis Kumar Nandy, Kiran Boppana, Samiron Phukan · 2025 · Journal of Computer-Aided Molecular Design
P4ward: An Automated Modeling Platform for Protac Ternary Complexes
Paula Jofily, Subha Kalyaanamoorthy · 2025 · Journal of Chemical Information and Modeling
Targeted protein degradation in pancreatic cancer: advances and challenges of PROTAC-based therapeutics
Mingyao Huang, Fang Wei, Jilong Cao, Hongzhou Jiang · 2025 · Bioorganic Chemistry
Shotgun Approach for PROTAC Ternary Complex Modeling and Evaluation
Tanfeng Zhao, Yi Qin Gao · 2025 · Journal of Chemical Information and Modeling
Computational assessment of the binding modes of the first VHL-recruiting PROTACs designed for oncogenic KRas G12C
Tanos C. C. França, Eleonore K. M. Delaire, Michael L. Drummond, Maximilian C. C. J. C. Ebert, Al Ajamian, Steven R. LaPlante · 2024 · New Journal of Chemistry
Exploiting Folding and Degradation Machineries To Target Undruggable Proteins: What Can a Computational Approach Tell Us?
Stefano Artin Serapian, Alice Triveri, Filippo Marchetti, Matteo Castelli, Giorgio Colombo · 2021 · ChemMedChem
Computational Modeling of PROTAC Ternary Complexes and Linker Design
Sven A. Miller, Grigorii V. Andrianov, Victoria Mischley, Khadija A. Wharton, Jesse J. Chen, John Karanicolas · 2022
Targeted degradation of EGFR 19Del by PROTACs suppresses tumor growth in non-small-cell lung cancer
Lianhua Piao, Ying Jun Gao, Yangyang Su, Qihui Li, Xiaofeng Yuan, Wangqiu He, Wanzhou Zhao, Janne Kulpakko, Pei-Chieng Cha, Shan Chang et al. · 2025 · Frontiers in Pharmacology
Ternary Complex Geometry and Lysine Positioning Guide the Generation of PROTAC-Induced Degradable Complexes.
Harish Kumar, M. E. Sobhia · 2026 · Journal of Physical Chemistry B
Foundation models and AI agents in oncology drug discovery
Yashwardhan Ghanwatkar, Pankaj Rajdeo, Ram I. Mahato · 2026 · Drug Discovery Today
Linker-Driven Sampling of PROTAC-Induced Ternary Complexes
Hongtao Zhao, Stefan Schießer, Christian Tyrchan, Werngard Czechtizky · 2026 · Journal of Medicinal Chemistry
Dual-function PROTAC suppresses ferroptosis and restores neuronal function via brain-targeted delivery
Tianyu Ma, Tianli Luo, Ming Wang · 2026 · Cell chemical biology
Proximity‐Inducing Bifunctional Molecules Beyond PROTACs
Sophia Lai, Ashley E. Modell, Amit Choudhary · 2022
Benchmarking of PROTAC docking and virtual screening tools
Evianne Rovers, Matthieu Schapira · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Efficient Sampling of PROTAC-Induced Ternary Complexes
Hongtao Zhao, Stefan Schießer, Christian Tyrchan, Werngard Czechtizky · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Resolving Enzyme–Substrate–Activator Ambiguity: A Minimalist Enzyme Kinetic Framework for PROTAC Design and Optimization
Bharath Srinivasan · 2025 · Journal of Medicinal Chemistry
How Feasible Is Docking of PROTACs to POI-E3L Complexes? Testing Physics-Based and ML-Based Docking Tools
Roberto Jiménez-Boi, Raúl Miñán, Chiara Pallara, Estrella Lozoya, Vı́ctor Guallar, Alexis Molina, Robert Soliva · 2025 · Journal of Chemical Information and Modeling
Discovery of the First-in-Class Protein Arginine Methyltransferase 1 PROTAC Degrader
Siqi Guo, Jianhao Li, Junjie Lin, Yan Chen, Chenyu Liu, Hao Liu, Z. X. He, Yiyang Zhu, Lei Wang, Fan Yang et al. · 2026 · Journal of Medicinal Chemistry
Degradation-based protein profiling in target identification and early-stage drug discovery of bioactive natural products
Zhihao Ni, Yi Shi, Yu Rao · 2026 · Targetome
Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on “undruggable” targets
Xun Lu, Jianliang Qin, Shuilin Dong, Yue Yuan, Zhanguo Zhang, B Zhang, Xiaoping Chen, Xiaoli Gan, Huifang Liang, Furong Liu · 2026 · Biomarker Research
ProxyBind: A compendium of binding sites for proximity-induced pharmacology
Evianne Rovers, Lihua Liu, Matthieu Schapira · 2022 · Computational and Structural Biotechnology Journal
Rationalize the Functional Roles of Protein–Protein Interactions in Targeted Protein Degradation by Kinetic Monte Carlo Simulations
Zhaoqian Su, Shanye Yin, Yinghao Wu · 2024 · The Journal of Physical Chemistry B
An in-silico approach for novel molecular glue design by rationalizing known molecular glue mediated ternary complex formation
Ben Geoffrey A S, Nagaraj M. Kulkarni, Deepak Agrawal, Nivedita Bharti, Rajappan Vetrivel, Kishan Gurram · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Computational approaches to aid PROTAC drug discovery
Sohini Chakraborti, Kirsten McAulay · 2025 · Elsevier eBooks
Transcription factor degraders
Manni Wang, Yuhao Wei, Xiaoling Ma · 2025 · Elsevier eBooks
Novel PROTACs with polyhedral alkanes as linkers for enhanced ALK degradation in drug-resistant NSCLC
Dongchen Chu, Huijie Han, Chaochun Wei, Xiaokun Zhang, Hong Yan, Juan Wang · 2025 · Bioorganic & Medicinal Chemistry
Attacking the “undruggable” target: The rise and evolution of targeted protein degradation technologies
Qihang Huang, Qianwen Mu, NiNa Liu, Gang Liu, Chao Liu · 2026 · Advanced Interventional Materials
Bellerophon: An Automated Tool for PROTAC Decomposition
Giulia Apprato, Matteo Bertola, Amelia LOCATELLI, Giulia Caron, Andrea Mauri, Giuseppe Ermondi · 2026 · ACS Medicinal Chemistry Letters
Next-generation strategies for PROTAC formulation: mechanistic insights and advanced formulation technologies
Azad Kumar Maurya, Luís Padrela, Ashish K. Agrawal, Ashish Kumar, D Manoj Kumar · 2026 · Expert Opinion on Drug Delivery
COMPASS: A Computational Pipeline to Identify Linkers Predicting Ubiquitinable PROTAC‐Induced Ternary Complexes
Sébastien Sueron, Sayyed Jalil Mahdizadeh, Éric Chevet, X. Guillory, François‐Hugues Porée, Leif Axel Eriksson · 2026 · ChemMedChem
From Ternary Modeling to Predictive PROTAC Design: A Computational Perspective
Joseph M. Schulz, Robert C. Reynolds, Stephan C. Schürer · 2026 · Journal of Chemical Information and Modeling
In silico designing of Targeted Protein Degraders
Susanta Samajdar · 2021 · Modern Approaches in Drug Designing
A Reliable and Sustainable Multicomponent Access to Protein Degraders
Irene Preet Bhela, Alice Ranza, M. Teresa Serafini, Tracey Pirali · 2021 · ChemRxiv
PROTAC-induced Protein Functional Dynamics in Targeted Protein Degradation
Kingsley Y Wu, Ta I Hung, Chia‐en A. Chang · 2024 · eLife
DNA-templated spatially controlled proteolysis targeting chimeras for CyclinD1-CDK4/6 complex protein degradation
Rong Zheng, Abhay Prasad, Deeksha Satyabola, Yang Xu, Hao Yan · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
P4ward: an automated modelling platform for Protac ternary complexes
Paula Jofily, Subha Kalyaanamoorthy · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
PROTAC-induced Protein Structural Dynamics in Targeted Protein Degradation
Kingsley Y Wu, Ta I Hung, Chia‐en A. Chang · 2025 · eLife
A Reliable and Sustainable Multicomponent Access to Protein Degraders
Irene Preet Bhela, Alice Ranza, M. Teresa Serafini, Tracey Pirali · 2021
Faculty Opinions recommendation of Major Advances in Targeted Protein Degradation: PROTACs, LYTACs, and MADTACs.
John A. Lowe III · 2021 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
A Reliable and Sustainable Multicomponent Access to Protein Degraders
Irene Preet Bhela, Alice Ranza, M. Teresa Serafini, Tracey Pirali · 2021
Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via in Silico Design
Hidetomo Yokoo, Norihito Shibata, Akinori Endo, Takahito Ito, Yuta Yanase, Yuki Murakami, Kiyonaga Fujii, Yasushi Saeki, Mikihiko Naito, Kosuke Aritake et al. · 2021 · ChemRxiv
Recommendation: Towards design of drugs and delivery systems with the Martini coarse-grained model — R1/PR5
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci et al. · 2022 · QRB Discovery
A Structural and Biophysical Perspective of Degrader Activity Through Ternary Complex Formation
Morgan S. Gadd, Marine C. Aublette · 2022 · Wiley eBooks
Recommendation: Towards design of drugs and delivery systems with the Martini coarse-grained model — R0/PR4
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci et al. · 2022 · QRB Discovery
Review: Towards design of drugs and delivery systems with the Martini coarse-grained model — R0/PR1
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci et al. · 2022 · QRB Discovery
Review: Towards design of drugs and delivery systems with the Martini coarse-grained model — R0/PR3
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci et al. · 2022 · QRB Discovery
Review: Towards design of drugs and delivery systems with the Martini coarse-grained model — R0/PR2
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci et al. · 2022 · QRB Discovery
WITHDRAWN: MEK1/2-Targeting PROTACs Promote the Collateral Degradation of CRAF in KRAS Mutant Cells
Carlos Herrera-Montávez, Alison Kurimchak, Xiaoping Hu, Jianping Hu, Jian Jun Jin, James S. Duncan · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Induction de proximité et dégradation de cibles thérapeutiques par les nouveaux dégradeurs : quels concepts, quels développements, quel futur ?
Michèle Reboud‐Ravaux · 2024 · Biologie Aujourd hui
Computational strategies for the design of proteolysis targeting chimera degraders: Artificial intelligence enabled PROTAC design
Rajamanikkam Kamaraj, Radim Nencka, Petr Pávek · 2024 · Annual reports in medicinal chemistry
The next frontier in drug discovery: Unveiling the pharmacological potential of proximity inducers
Natalie Holmberg‐Douglas, Katherine N. Keenan, Felix González-López de Turiso, Eugene P. Chekler, Veerabahu Shanmugasundaram, Jennifer R. Riggs, Christoph W. Zapf · 2025 · Elsevier eBooks
Characterization of PROTACs by Ternary Complex Landscape Exploration using Monte Carlo simulations
Anna M. Díaz-Rovira, Carles Perez‐Lopez, Jordi Martín-Pérez, Chiara Pallara, Lucía Díaz, Vı́ctor Guallar · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Harnessing the power of traditional Chinese medicine for targeted protein degradation
Zheng Wu, Bo Zhu, Yiwen Shou, Hongwei Guo · 2025 · Elsevier eBooks
Protease-mediated degradation
Lu Yang, Haiting Duan, Xinfei Mao, Bizhi Li, Jinxin Che, Xiaowu Dong · 2025 · Elsevier eBooks
Generative AI Framework SynGlue for the Rational Design of Clinically relevant Protein Degraders
Saveena Solanki, Sanjay Kumar Mohanty, Shiva Satija, Sonam Chauhan, N.V.M. Rao Bandaru, Sandeep Dukare, Nirbhay Kumar Tiwari, R. Naveen Kumar, A B Aravind, Subhendu Mukherjee et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
AI-aided drug development for protein degraders: Design, lead identification, and optimization
Reagon Karki, Bishab Pokharel, Andrea Zaliani, Johanna Huchting, Philip M. Gribbon · 2025 · Annual reports in medicinal chemistry